According to the results of GO and KEGG pathway enrichment analyses, we found that the effects of the ZS-BZ herb pair against gastric cancer may be due to the active compounds of the ZS-BZ herb pair, especially for luteolin and naringenin which could influence the regulation of the PI3K-Akt and IL-17 signaling pathway. Here, AKT1 is linked to gastric cancer.